2023-2027 World Immunohematology and Infectious Disease NAT Screening Database for 92 Countries: 2022-2027 Volume and Sales Segment Forecasts for over 40 Transfusion Medicine Tests
This unique 92-country database provides information and analysis not available from any other published source, including 2022 supplier shares and 2022-2027 volume and sales forecasts for over 40 tests.
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT
Geographic Regions and Countries
Asia-Pacific
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam
This product is an industry database. Each license type allows a set number of users to access the database. Please select an option from the list below. This product is an industry database. This is a single user license, allowing one user access to the product. The product is in Excel format. This product is an industry database. This is an enterprise license, allowing all employees within your organization access to the product. The product is in Excel format.
2023-2027 World Immunohematology and Infectious Disease NAT Screening Database for 92 Countries: 2022-2027 Volume and Sales Segment Forecasts for over 40 Transfusion Medicine Tests
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
*Required Information
This website uses cookies to ensure you get the best experience. Learn more